For in vitro diagnostic use. Others Elecsys CMV IgG IVD Elecsys® CMV IgG CPS_000457 09118551190 CMV IgG Elecsys E2G 300 V2 Elecsys CMV IgG 07613336198469 Reagents, kits 300 tests cobas e 402/801 true 07027117190 CMV IgG Elecsys E2G 300 Elecsys CMV IgG 04015630940172 Reagents, kits 300 tests cobas e 402/801 true 09338977160 CMV IgG Elecsys cobas e 100 V2 Elecsys CMV IgG 07613336193082 Reagents, kits 100 tests cobas e 411/601/602 true 09118543190 CMV IgG Elecsys cobas e 100 V2 Elecsys CMV IgG 07613336190616 Reagents, kits 100 tests cobas e 411/601/602 true 04784596190 CMV IgG Elecsys cobas e 100 Elecsys CMV IgG 04015630923489 Reagents, kits 100 tests cobas e 411/601/602 true 07309325160 CMV IgG Elecsys cobas e 100 Elecsys CMV IgG 04015630937172 Reagents, kits 100 tests cobas e 411/601/602 true 09118551501 Elecsys CMV IgG en 1 FF00000005DDEC0E FF00000005DDEB0E 09118551190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. 09118551500 Elecsys CMV IgG en 1 FF00000004D5E40E FF00000004D5E30E 09118551190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of IgG antibodies to cytomegalovirus in human serum and plasma.Results with this assay are used to indicate past or recent infection with CMV.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09118551500 Elecsys CMV IgG en 2 FF00000005FFA70E FF00000004D5E40E 09118551190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of IgG antibodies to cytomegalovirus in human serum and plasma.Results with this assay are used to indicate past or recent infection with CMV.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027117501 Elecsys CMV IgG en 3 FF00000005C86F0E FF00000001DD920E 07027117190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys CMV IgG assay is an in vitro qualitative test for the detection of IgG antibodies to CMV in human serum, lithium-heparin plasma, K2‑EDTA plasma, and K3‑EDTA plasma. The test is intended as an aid in the determination of the serological status to CMV in individuals in which a CMV IgG test was ordered, including pregnant women. Performance characteristics have not been evaluated in immunocompromised or immunosuppressed individuals. This test is not intended for use in neonatal screening or for use at point of care facilities. This test is not intended for use in screening blood and plasma donors.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027117500 Elecsys CMV IgG en 3 FF00000003EEFF0E FF0000000197910E 07027117190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of IgG antibodies to cytomegalovirus in human serum and plasma.Results with this assay are used to indicate past or recent infection with CMV.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07027117500 Elecsys CMV IgG en 4 FF00000004721E0E FF00000000E89A0E 07027117190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of IgG antibodies to cytomegalovirus in human serum and plasma.Results with this assay are used to indicate past or recent infection with CMV.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09338977501 Elecsys CMV IgG en 1 FF00000005DF3A0E FF00000005DF3A0E 09338977160 618 cobas e 411 2325 cobas e 602 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys CMV IgG assay is an in vitro qualitative test for the detection of IgG antibodies to CMV in human serum, lithium-heparin plasma, K2‑EDTA plasma, and K3‑EDTA plasma. The test is intended as an aid in the determination of the serological status to CMV in individuals in which a CMV IgG test was ordered, including pregnant women. Performance characteristics have not been evaluated in immunocompromised or immunosuppressed individuals. This test is not intended for use in neonatal screening or for use at point of care facilities. This test is not intended for use in screening blood and plasma donors.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e 411 and cobas e 602 immunoassay analyzers. en 09118543500 Elecsys CMV IgG en 1 FF00000004D78F0E FF00000004D78F0E 09118543190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of IgG antibodies to cytomegalovirus in human serum and plasma.Results with this assay are used to indicate past or recent infection with CMV.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 04784596500 Elecsys CMV IgG en 12 FF000000051E7E0E FF00000000221F0E 04784596190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of IgG antibodies to cytomegalovirus in human serum and plasma.Results with this assay are used to indicate past or recent infection with CMV.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07309325501 Elecsys CMV IgG en 2 FF00000003CCE70E FF00000000EE1D0E 07309325160 618 cobas e 411 2325 cobas e 602 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys CMV IgG assay is an in vitro qualitative test for the detection of IgG antibodies to CMV in human serum, lithium-heparin plasma, K2‑EDTA plasma, and K3‑EDTA plasma. The test is intended as an aid in the determination of the serological status to CMV in individuals in which a CMV IgG test was ordered, including pregnant women. Performance characteristics have not been evaluated in immunocompromised or immunosuppressed individuals. This test is not intended for use in neonatal screening or for use at point of care facilities. This test is not intended for use in screening blood and plasma donors.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e 411 and cobas e 602 immunoassay analyzers. en